SHROOM2 and breast cancer: The results revealed a significant association between SHROOM2 expression and poorer survival in ER-positive (Fig. 3H), PR-positive (Fig. 3J), and luminal A BC (Fig. 3L) groups, suggesting a strong correlation between these traits and SHROOM2 levels.